𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5076 POSTER Phase II Study of Vinorelbine Plus Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes

✍ Scribed by Kwon, H.; Oh, S.Y.; Kim, S.H.; Lee, S.; Lee, J.H.; Kim, H.J.


Book ID
122423438
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
43 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Trastuzumab plus vinorelbine or taxane c
✍ Harold J. Burstein; Aparna Keshaviah; Ari D. Baron; Ronald D. Hart; Rosemary Lam πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 157 KB

## Abstract ## BACKGROUND. The optimal trastuzumab‐based chemotherapy regimen for HER2‐overexpressing, metastatic breast cancer is not known. The __tr__astuzumab __a__nd __vi__norelbine __o__r __ta__xane (TRAVIOTA) study was a prospective, multicenter, randomized trial that was designed to compare